Waldencast plc (MLKWF)
As-reported financials and SEC filings for Waldencast plc. The latest annual period is FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About Waldencast plc
Waldencast plc is a global beauty and wellness company that develops, acquires, and scales purpose-driven brands. Its main brands include Obagi Medical and Milk Makeup, which it operates through a multi-brand platform to manage and grow in the global beauty market. The company serves consumers seeking beauty and wellness products and maintains offices and studios in locations such as London, California, Texas, and New York.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Waldencast
- Revenue fell 0.7% to $272M in FY2025, slower than the 25.5% the year before.
- Operating margin is now a 80.0% loss in FY2025, from 0.6% in FY2020.
- Free cash flow was negative $16M in FY2025.
- Net loss widened to $230M in FY2025, from $42M in FY2024.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Waldencast’s fundamentals sit among the 131 Consumer Staples companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Waldencast’s net margin of -84.4% is the lowest of the 121 Consumer Staples companies reporting it. Waldencast’s operating margin of -80.0% ranks in the 1st percentile of the 117 Consumer Staples companies reporting it. Waldencast’s gross margin of 67.3% ranks in the 92nd percentile of the 113 Consumer Staples companies reporting it.
No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|---|
| Revenue | $272.1M | $273.9M | $218.1M | $142.5M | $94.4M |
| Gross profit | |||||
| Operating income | $-217.5M | $-58.6M | $-81.9M | $-1.6M | $528,000 |
| Pre-tax income | $-262.2M | $-48.5M | $-112.9M | $-10.0M | $-5.8M |
| Net income | $-229.7M | $-42.4M | $-90.0M | $-19.6M | $-2.4M |
| Diluted EPS | $-2.01 | $-0.39 | $-0.99 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|---|
| Cash and equivalents | $30.4M | $14.8M | $21.1M | $12.8M | $8.6M |
| Current assets | $126.9M | $103.6M | $107.3M | $59.0M | $166,792 |
| Total assets | $746.2M | $975.9M | $1.04B | $184.6M | $166,792 |
| Current liabilities | $74.5M | $76.9M | $62.7M | $40.8M | $177,743 |
| Long-term debt | $135.8M | $137.1M | $151.3M | $103.4M | — |
| Total liabilities | $246.1M | $245.9M | $273.4M | $145.3M | $177,743 |
| Total equity | $500.1M | $729.9M | $769.3M | $39.2M | $-10,951 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|---|
| Operating cash flow | $-12.8M | $-8.8M | $-29.8M | $3.5M | $-7.4M |
| Capital expenditure | $3.4M | $2.7M | $1.6M | $424,000 | $1.1M |
| Free cash flow |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Company facts
Selected SEC filings
Largest Consumer Staples peers
Monitor MLKWF
Get an alert when Waldencast files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor MLKWF freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.